ArticleCancer reports (Hoboken, N.J.)2025
First Comprehensive Assessment of Quality of Life in Cancer Patients in Afghanistan: Insights From Herat Regional Hospital.
Article in Cancer reports (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- First Comprehensive Assessment of Quality of Life in Cancer Patients in Afghanistan: Insights From Herat Regional Hospital.Cancer reports (Hoboken, N.J.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study marks the first extensive evaluation of quality of life (QoL) among cancer patients in Afghanistan, carried out at the Oncology Department of Herat Regional Hospital. Its primary objective was to assess the QoL of cancer patients and to determine key factors influencing it, utilizing the validated European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 instrument.
aimsThe study aimed to determine overall QoL levels among Afghan cancer patients and to examine the impact of sociodemographic and clinical characteristics, including disease stage and gender differences, on functional and symptom related domains. METHODS AND
resultsA total of 230 patients diagnosed with cancer participated in this cross-sectional survey conducted between February and May 2024. Data regarding sociodemographic characteristics and clinical profiles were collected, and QoL outcomes were examined across both functional and symptom-related domains. The findings indicated that esophageal and gastric cancers were the most common types observed, with the majority of patients presenting at stage two of the disease. Among the functional domains, cognitive functioning received the highest scores, whereas social functioning scored the lowest. Financial hardship emerged as the most burdensome symptom reported. Disease progression, marked by advancing cancer stages, was associated with significant declines in physical and role functioning, along with increases in symptoms such as dyspnea and insomnia. Gender differences were notable, with male patients reporting higher overall QoL compared to female patients. Economic challenges were found to have a considerable negative effect on QoL outcomes.
conclusionAs a pioneering study in Afghanistan, these results emphasize the pressing need for interventions that address the physical, psychological, and economic hardships faced by cancer patients. The study further stresses the importance of promoting early diagnosis, developing individualized treatment plans, and providing comprehensive supportive care to enhance patient well-being. These insights offer a foundation for developing cancer care policies and integrating standardized QoL assessment tools within clinical practice in Afghanistan and similar resource-limited environments. These findings provide crucial evidence for policymakers to develop targeted, gender-sensitive interventions to mitigate financial toxicity and improve supportive care within Afghanistan's fragile health system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.